| Value | ₹107.0 Cr |
|---|
NSE filing, NSE: DPSCLTD. Summary written from the filing by ALFA Finder's alert engine.
Dpsc Limited: key numbers
- Share price
- ₹6.28
- Market cap
- ₹611.5 Cr
- Revenue (annual)
- ₹683.0 Cr
- Net profit (annual)
- ₹12.81 Cr
- P/E (TTM)
- 43.7×Sector 21.6×
- Promoter holding
- 59.14%-0.01% QoQ
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dpsc Limited
All →DPSC Q1 FY27 Results: Net Profit ₹4.2 Cr, Up 40.0% YoY
DPSC Limited reported revenue from operations of ₹186.9 Cr (+14.2% YoY) and net profit of ₹4.2 Cr (+40.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹4.2 Cr · +40.0% YoY
DPSC Insolvency Petition
DPSC Limited (under CIRP) reported that its 8th CoC meeting approved all remaining agenda items except consultancy fees to a related party. No new monetary value or resolution plan outcome is disclosed.
DPSC Insolvency Petition
India Power Corporation Limited announced the 9th meeting of its Committee of Creditors, scheduled for October 15, 2026, to discuss the extension of the CIRP timeline.
DPSC Board Meeting Date
India Power Corporation Ltd, currently under CIRP, has scheduled a meeting of the suspended Board and RP on October 29, 2026, to consider quarterly financial results.
DPSC Other Announcement
DPSC Limited (now India Power Corporation) confirmed its website is updated and functional per SEBI LODR Reg 46. This is a routine compliance intimation with no business or financial impact.
DPSC Insolvency Petition
India Power Corporation Limited, currently under CIRP, announced that the Committee of Creditors approved the Request for Resolution Plan document and related evaluation parameters.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.